Coronaios: Historic day for Israel on November 1 – The first human vaccine trials are coming

Israel will begin the first human trials of a SovS-CoV-2 Covid-19 vaccine on November 1. The vaccine is being developed by the Israel Institute for Biological Research (IIBR), which is overseen by the country’s Ministry of Defense. The vaccine, called BriLife (from the Israeli word “health” and the English word “life”) tested on small and large animals since March. The Israeli Ministry of Health and the Special Supervisory Committee for Medical Experiments have now given the “green light” to pass the tests to the next stage, to 80 volunteers aged 18 to 55, who will be monitored for three weeks to whether they will develop coronavirus antibodies, as well as possible side effects. The start will be with two volunteers on November 1 and, depending on their reactions, the vaccine will be given to others at two medical centers in Tel Aviv and Jerusalem. Everyone will receive a single dose, while some will receive a placebo instead of a regular one. After a few hours of observation in the hospital, the volunteers will go home, where they will continue their monitoring. A second phase of the vaccine will be administered to 960 people over the age of 18, which will begin in December in various Israeli hospitals. If all goes well, the third phase of a large-scale trial of 30,000 volunteers will begin next spring (April or May 2021), according to Reuters and the Jerusalem Post and Times of Israel. and the third phase is completed successfully and the vaccine proves safe and effective, then approval for mass production will be given. The IIBR Institute has already produced more than 25,000 doses of the vaccine for the first two phases of clinical trials in humans. The institute has a production capacity of 15 million vaccines. “Our ultimate goal is to produce 15 million doses for the people of the state of Israel and our close neighbors,” said Samuel Sapira, director of the institute. our vaccine, I believe in it and in the ability of the scientists of our Institute who developed it “. The population of Israel is about nine million and the country has so far reported 2,372 deaths from the coronavirus. Israeli Defense Minister Benny Gandz, visiting the Institute, which is believed to be involved in biological and chemical weapons, among other things. protruding coronavirus proteins (“crowns”), which are then recognized by the body as Covid-19, resulting in the production of antibodies. “This is a state-of-the-art vaccine at the forefront of global technology that provides the required level of protection in a single dose,” the Israeli Defense Ministry said. So far, several vaccine trials are in various stages around the world, companies Pfizer, Johnson & Johnson, AstraZeneca and Moderna, Russia, China etc. Follow it on Google News and be the first to know all the news See all the latest News from Greece and the World, at

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *